PeptideKey News
Nature study of 28,000 GLP-1 users identifies GLP1R and GIPR gene variants predicting weight loss efficacy and side effects for semaglutide and tirzepatide.
This article is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.